lumacaftor
Jump to navigation
Jump to search
Indications
- used in combination with ivacaftor for treatment of cystic fibrosis CFTR mutation F508del
Dosage
- 200 mg
Mechanism of action
- CFTR potentiator
More general terms
Component of
References
- ↑ FDA News Release. July 2, 2015 FDA approves new treatment for cystic fibrosis http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm453565.htm